Stoke Therapeutics to Present at the SVB Securities Global Biopharma Conference

Author's Avatar
Feb 07, 2023

Stoke+Therapeutics%2C+Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the virtual SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 4:20 p.m. ET.